Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01193192 · ClinicalTrials.gov registry record

A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy

A clinical trial, sponsored by Pamlab, L.L.C..

Terminated
Registry status
30
Enrollment target

NCT01193192: Clinical Trial study, sponsored by Pamlab, L.L.C..

NCT01193192 is a clinical trial that was terminated before completion, run by Pamlab, L.L.C.. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01193192 was terminated before completion, sponsored by Pamlab, L.L.C..

TERMINATED
Registry status
30 participants
Enrollment target

Study Summary

This study is a multi-site, retrospective chart review to determine the effect of Neevo® or NeevoDHA® (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for the dietary management of women under a doctor's care who face high risk pregnancies, older overactive bladder (OB) patients and patients unable to fully metabolize folic acid. Data will be collected from existing patient charts of subjects administered Neevo® or NeevoDHA® daily compared to subjects administered a prenatal vitamin daily.

Primary Outcome

To determine the effect of Neevo®/NeevoDHA® versus standard prenatal vitamins on mean hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy.

Interventions

  • OTHER Neevo®
  • OTHER Prenatal vitamins

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-07
Est. Completion 2010-11
Pamlab, L.L.C.

2 total trials

Why NCT01193192 stopped before completion

NCT01193192 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Neevo® is the first listed.

NCT01193192 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01193192 about?

NCT01193192 is a clinical study titled "A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy". This study is a multi-site, retrospective chart review to determine the effect of Neevo® or NeevoDHA® (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for th...

What is the current status of trial NCT01193192?

This trial is currently terminated. The enrollment target is 30 participants. The study started on 2010-07. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01193192?

The interventions under investigation include: Neevo® (OTHER), Prenatal vitamins (OTHER).

Who is sponsoring clinical trial NCT01193192?

This trial is sponsored by Pamlab, L.L.C., which has 2 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01193192, the US trial registry maintained by the National Library of Medicine. NCT01193192 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.